Journal: Frontiers in Immunology

Article Title: Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort

doi: 10.3389/fimmu.2020.01727

Figure Lengend Snippet: Summary of age at diagnosis, age at ERT initiation, anti-rhGAA IgG antibody titer, B cell, and LVMI.

Article Snippet: Anti-rhGAA IgG antibody titers were determined by Sanofi Genzyme (Framingham, MA, USA) by enzyme-linked immunosorbent assay and confirmed using radioimmunoprecipitation as previously described ( ).

Techniques: Biomarker Discovery

Journal: Frontiers in Immunology

Article Title: Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort

doi: 10.3389/fimmu.2020.01727

Figure Lengend Snippet: B cell reconstitution, infections, vaccination, anti-rhGAA IgG antibody titers, and ITI protocol deviations in IPD patients treated with immunomodulation.

Article Snippet: Anti-rhGAA IgG antibody titers were determined by Sanofi Genzyme (Framingham, MA, USA) by enzyme-linked immunosorbent assay and confirmed using radioimmunoprecipitation as previously described ( ).

Techniques: Cell Recovery, Infection

Journal: Molecular Genetics and Metabolism Reports

Article Title: Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy

doi: 10.1016/j.ymgmr.2024.101126

Figure Lengend Snippet: Patient characteristics before therapy with neoGAA. HCM, hypertrophic cardiomyopathy; PEG, percutaneous endoscopic gastrostomy.

Article Snippet: Antibodies against rhGAA and neoGAA were tested by LabCorp, California, USA.

Techniques: Biomarker Discovery

Journal: Molecular Genetics and Metabolism Reports

Article Title: Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy

doi: 10.1016/j.ymgmr.2024.101126

Figure Lengend Snippet: Outcomes after treatment with neoGAA. eow, every other week; HCM, hypertrophic cardiomyopathy; 6MWT, 6 min walk test; PEG, percutaneous endoscopic gastrostomy.

Article Snippet: Antibodies against rhGAA and neoGAA were tested by LabCorp, California, USA.

Techniques:

Journal: Molecular Genetics and Metabolism Reports

Article Title: Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy

doi: 10.1016/j.ymgmr.2024.101126

Figure Lengend Snippet: Changes in anti-rhGAA and anti-neoGAA antibodies after starting treatment with neoGAA in cases #1 (a) and #2, (b).

Article Snippet: Antibodies against rhGAA and neoGAA were tested by LabCorp, California, USA.

Techniques: